Emphysema News and Research RSS Feed - Emphysema News and Research

Emphysema is a debilitating disease that afflicts more than three million Americans. The disease is caused primarily by smoking and leads to a progressive, irreversible breakdown of lung tissue. This breakdown reduces the amount of lung tissue available for gas exchange and also impairs the lung's ability to inflate and deflate normally. As the disease advances, the most damaged areas of the lung over inflate within the chest cavity, trapping air and preventing the healthier lung areas from functioning normally. Eventually breathing becomes more difficult, leaving patients constantly feeling out-of-breath.
Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

The prevalence of past-year generalized anxiety disorder (GAD) for adults aged 50 and older with chronic obstructive pulmonary disease (COPD) is much higher compared to older adults without COPD (5.8% vs 1.7%), according to a new study published by University of Toronto researchers. [More]
MUSC researchers receive $1.68 million NIH grant to study better treatment for chronic pancreatitis, diabetes

MUSC researchers receive $1.68 million NIH grant to study better treatment for chronic pancreatitis, diabetes

MUSC researchers received a $1.68 million National Institutes of Health grant to explore a better treatment for chronic pancreatitis, with the hopes that it also may shed light on a future cure for patients with type 1 diabetes. [More]
Study: Low-dose CT screening can reduce lung cancer mortality by 20% in high-risk population

Study: Low-dose CT screening can reduce lung cancer mortality by 20% in high-risk population

A national study involving 53,000 patients and 11 institutions (including Wake Forest Baptist) compared CT screens with chest X-rays and found that the scanning reduced lung cancer mortality by 20 percent in this high-risk population. [More]
Endoscopic submucosal dissection appears to be effective treatment for patients with throat cancer

Endoscopic submucosal dissection appears to be effective treatment for patients with throat cancer

According to a study in the December issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy, endoscopic submucosal dissection (ESD) appears to be a safe and effective minimally invasive treatment for patients with superficial pharyngeal (throat) cancer. [More]
BTG receives 510k clearance for LC Bead LUMI

BTG receives 510k clearance for LC Bead LUMI

BTG plc, a global specialist healthcare company, today announced it has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs). [More]
Preventable comorbidities common in cerebral palsy patients

Preventable comorbidities common in cerebral palsy patients

Medical comorbidities are common in patients with cerebral palsy and may impact on their mobility, report researchers. [More]
Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD. [More]
Alaska pollock gelatin can be used to treat pulmonary diseases

Alaska pollock gelatin can be used to treat pulmonary diseases

In recent years, patients with pulmonary emphysema have been increasing mainly among middle-aged and elderly males due to aging and excessive smoking. Emphysema makes brittle lungs, and in severe cases, holes develop in the lung tissue, causing air leakage. Researchers at NIMS developed a new sealant to close holes developed in lungs and blood vessels using Alaska pollock gelatin. [More]
Henry Ford Hospital pulmonologist advocates for raising the smoking age to 21

Henry Ford Hospital pulmonologist advocates for raising the smoking age to 21

Henry Ford Hospital pulmonologist Daniel Ouellette, M.D., who during his 31-year career in medicine has seen the harmful effects of smoking on his patients, advocates for raising the smoking age to 21. [More]
Pitt investigators to lead $15 million federal initiative to manage breathing disorder clinical trials

Pitt investigators to lead $15 million federal initiative to manage breathing disorder clinical trials

The University of Pittsburgh Graduate School of Public Health and School of Medicine investigators will be leading a $15 million, five-year federal initiative to manage national clinical trials aimed at developing new treatments for breathing disorders. [More]
UK Biobank genetic study shows link between lung disease and smoking behaviour

UK Biobank genetic study shows link between lung disease and smoking behaviour

New research published in The Lancet Respiratory Medicine and presented at this year's European Respiratory Society meeting in Amsterdam presents the first analyses of genetic data from the UK Biobank that reveal new associations with lung disease and smoking behaviour. [More]
Surgeons participate in record-setting day of organ transplantation at Baylor University Medical Center

Surgeons participate in record-setting day of organ transplantation at Baylor University Medical Center

One week ago, surgical teams took part in a record-setting day of organ transplantation at Baylor University Medical Center at Dallas. Surgeons on the medical staff performed nine organ transplants on seven patients in one calendar day. [More]
UT Southwestern's Pulmonary Hypertension Program continues to grow in the U.S.

UT Southwestern's Pulmonary Hypertension Program continues to grow in the U.S.

When Derrik Neal began having trouble breathing, he initially assumed it was because he was overweight. But after blacking out several times, he learned he had idiopathic pulmonary hypertension. Survival rates at the time he was diagnosed were five years or less - three or less if undetected. [More]
Study shows possibility of using embryonic stem cells to repair damaged lung tissue

Study shows possibility of using embryonic stem cells to repair damaged lung tissue

Collectively, such diseases of the airways as emphysema, bronchitis, asthma and cystic fibrosis are the second leading cause of death worldwide. More than 35 million Americans alone suffer from chronic respiratory disease. Weizmann Institute scientists have now proposed a new direction that could, in the future, lead to the development of a method for alleviating some of their suffering. [More]
STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that STIOLTO RESPIMAT (tiotropium bromide and olodaterol) Inhalation Spray is now available by prescription at pharmacies across the United States. [More]
Long-term smokers and ex-smokers have respiratory-related impairments

Long-term smokers and ex-smokers have respiratory-related impairments

More than half of long-term smokers and ex-smokers who are considered disease-free because they passed lung-function tests have respiratory-related impairments when more closely evaluated with lung imaging, walking and quality-of-life tests. Many of those people likely have the earliest stages of chronic obstructive pulmonary disease, an incurable progressive disease (COPD) that is the third leading cause of death in the United States. [More]
Improving air quality could prevent pollution-related deaths worldwide

Improving air quality could prevent pollution-related deaths worldwide

Improving air quality -- in clean and dirty places -- could reduce pollution-related deaths worldwide by millions of people each year. That finding comes from a team of environmental engineering and public health researchers who developed a global model of how changes in outdoor air pollution could lead to changes in the rates of health problems such as heart attack, stroke and lung cancer. [More]
Experimental Zephyr endobronchial valve provides good result in emphysema patient at UAB

Experimental Zephyr endobronchial valve provides good result in emphysema patient at UAB

In late March, physicians at the University of Alabama at Birmingham carefully threaded a one-way valve the size of a black-eyed pea into the lower lobe of Dennis Bullock's left lung. Bullock, a 67-year-old emphysema patient, was the fourth person at UAB to receive the experimental Zephyr endobronchial valve. [More]
Therapy for genetically-caused emphysema slows progression of lung disease

Therapy for genetically-caused emphysema slows progression of lung disease

A landmark clinical study in the Lancet provides convincing evidence that a frequently overlooked therapy for genetically-caused emphysema is effective and slows the progression of lung disease. [More]
Regular use of aspirin may slow the progression of early emphysema, new research shows

Regular use of aspirin may slow the progression of early emphysema, new research shows

Regular use of aspirin may help slow the progression of early emphysema, according to new research presented at the 2015 American Thoracic Society International Conference. [More]
Advertisement